Your session is about to expire
← Back to Search
5-MeO-DMT for Pharmacokinetics, Safety, and Tolerability
Study Summary
This trial studies the effects of an injection of 5-MeO-DMT on healthy people, to see how safe and well-tolerated it is.
- Pharmacokinetics
- Safety
- Tolerability
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- You have had a strong allergic reaction to the investigational drug or any similar products, or have experienced severe allergic reactions to other medications.
- Group 1: Cohort 1 - 0.5 mg single-dose
- Group 2: Cohort 2 - 2.5 mg single-dose
- Group 3: Cohort 3 - 4.5 mg single-dose
- Group 4: Cohort 4 - 7 mg single-dose
- Group 5: Cohort 5 - 10 mg single-dose
- Group 6: Cohort 6 - 13 mg single-dose
- Group 7: Cohort 7 - multiple-dose, 3 hour interval
- Group 8: Cohort 8 - multiple-dose, 3 hour interval
- Group 9: Cohort 9 - multiple-dose, 3 hour interval
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this research endeavor inviting individuals who are 60 or older to participate?
"This research project is for people between 18 and 65, but there are separate studies with different age brackets; 4 clinical trials accommodate those below the age of consent while 42 cater to seniors."
Are participants still being admitted to this experiment?
"Per the information listed on clinicaltrials.gov, this investigation is open to new participants. The trial was first posted December 27th 2022 and has seen a recent update of January 13th 2023."
How many participants are being recruited for this medical trial?
"Affirmative. Clinicaltrials.gov attests that this research endeavour, which was first advertised on December 27th 2022, is actively searching for participants. A total of 54 individuals are needed to be recruited from a single location."
Has the FDA granted approval of a 0.5 mg single-dose regimen for Cohort 1?
"As this is a Phase 1 trial, and there is minimal scientific evidence to back up the safety and efficacy of Cohort 1 - 0.5 mg single-dose, it was assigned a score of 1 on our rating scale."
Am I eligible to take part in this experiment?
"This safety study is open to 54 individuals aged 18 and 65 who are free of any health problems. To be eligible, people must also fit the following criteria: Healthy adult male or female., At least 18 years old but no more than 65 years old, BMI between 18.0 kg/m2 and 32.0 kg/m2 (inclusive)."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger